The trademark TELLIUS was filed by Hangzhou Biotest Biotech Co., Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 27, 2022, and received one opposition filed on December 12, 2022 by Fresenius Kabi Deutschland GmbH on Likelihood of confusion. the opponent was represented by KNPZ Rechtsanwälte – Klawitter Neben Plath Zintler – Partnerschaftsgesellschaft mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 12, 2022
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Chemical preparations for the diagnosis of pregnancy
Diagnostic preparations for medical purposes
All of the aforesaid goods only being in relation to pregnancy testing preparations, infectious disease testing preparations, cardiovascular disease testing preparations, drug testing preparations.
The mark was filed in class 10 with following description of goods: